Objective To explore the therapeutic effect of Qingre Bawei Capsules combined with oseltamivir in treatment of influenza.Methods Patients(104 cases)with influenza in Chongming Hospital Affiliated to Shanghai University of Medicine&Health Sciences from March 2022 to March 2024 were randomly divided into control(52 cases)and treatment(52 cases).Patients in were po administered with Phosphate Capsules,1 grain/time,twice daily.Patients in the were po administered with Qingre Bawei Capsules,3-5 grains/time,1-2 times daily.Patients in two 5 d.After treatment,the clinical evaluations were evaluated,the symptoms improved time,the levels of SOD,IL-6,IFN-γ and TNF-α in before and after compared.Results After treatment,the effective rate(96.15%)was higher(82.69%,P<0.05).After treatment,the improvement time of fever,headache,nasal congestion and body muscle soreness in the treatment group was shorter than that in the control group(P<0.05).After treatment,the levels of IL-6 and TNF-α were significantly decreased,but SOD and IFN-γ were increased in two groups(P<0.05).After treatment,the levels of IL-6 and TNF-α in the treatment group were lower than those in the control group,and the levels of SOD and IFN-γ were higher than those in the control group(P<0.05).Conclusion Qingre Bawei Capsules combined with oseltamivir in treatment of influenza can effectively alleviate cold symptoms,which can also improve cellular immune function and regulate the reduction of inflammatory factor content.
万方数据
